Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
College outlined 'fragile' financial position in letter to enterprise minister
'Stay cautious' after global disruption to Microsoft
Tiny percentage of government buildings have solar panels
Douglas East candidate says integrity of whole election has been cast into doubt'